← Feed

Spetzler David Baxley

SEC Form 4 insider
President · Caris Life Sciences, Inc. ($CAI)
1 thesis · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CAISEC Form 4bearish
Spetzler David Baxley · President at Caris Life Sciences, Inc. · 4h agono track record yet
Sold 597,212 @ $24.84 avg · $14,834,107 · 2026-09-03

Form 4: Spetzler David Baxley sold CAI

Spetzler David Baxley (President at Caris Life Sciences, Inc.) reported an open-market sale of 597,212 shares of CAI at an average $24.84, roughly $14,834,107, in a Form 4 filed 2026-09-04.

View filing on SEC.gov →

End of results.